Drug Shortage Report for PEMETREXED DISODIUM FOR INJECTION

Last updated on 2020-11-19 History
Report ID 127619
Drug Identification Number 02394227
Brand name PEMETREXED DISODIUM FOR INJECTION
Common or Proper name PEMETREXED DISODIUM FOR INJ 500MG
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) PEMETREXED
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 50ml
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-10-28
Estimated end date 2021-01-31
Actual end date
Shortage status Actual shortage
Updated date 2020-11-19
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-11-19 French Compare
v3 2020-11-19 English Compare
v2 2020-10-30 French Compare
v1 2020-10-30 English Compare